The Use of Frusemide and Epsilon‐Amino‐Caproic‐Acid in Transurethral Prostatectomy
- 1 October 1974
- journal article
- clinical trial
- Published by Wiley in British Journal of Urology
- Vol. 46 (5), 521-525
- https://doi.org/10.1111/j.1464-410x.1974.tb03850.x
Abstract
Summary: A randomised prospective clinical trial has been performed to assess the effectiveness of giving e‐amino‐caproic‐acid to patients routinely receiving a frusemide diuresis, following transurethral prostatectomy. A significant reduction in postoperative blood loss, and fewer problems related to catheter management and infection were noted in the group of patients receiving E.A.C.A.We wish to thank Dr D. Pearce and Dr W. E. Waters for their help in devising the trial, Mr R. Rumble and Mr B. Howard for their technical assistance and the nursing staff of Southampton General Hospital for their cooperation.This publication has 9 references indexed in Scilit:
- FACTORS REDUCING THE RATE OF INFECTION AFTER TRANS-URETHRAL SURGERYBritish Journal of Urology, 1972
- The effect of the fibrinolytic inhibitor epsilonaminocaproic acid on the incidence of deep-vein thrombosis after prostatectomyBritish Journal of Surgery, 1972
- The value of frusemide in 110 consecutive prostatectomiesBritish Journal of Surgery, 1972
- THE USE OF FRUSEMIDE (LASIX) IN THE POST-OPERATIVE MANAGEMENT OF PROSTATECTOMYBritish Journal of Urology, 1969
- Frusemide and prostatectomyBritish Journal of Surgery, 1969
- Post-prostatectomy haematuria treatment with ϵ-amino-caproic acidBritish Journal of Surgery, 1967
- AMINOCAPROIC ACID IN THE CONTROL OF HÆMORRHAGE AFTER PROSTATECTOMY: A Controlled TrialThe Lancet, 1966
- AMINOCAPROIC ACID IN THE CONTROL OF HÆMORRHAGE AFTER PROSTATECTOMY: Safety of Aminocaproic Acid—a Controlled TrialThe Lancet, 1966
- The Use of Epsilon Aminocaproic Acid, a Potent Inhibitor of Fibrinolytic Activity, in the Management of Postoperative HematuriaJournal of Urology, 1961